Professor Schellekens maakt medicijnen zelf - Zembla - BNNVARA
PDF) Making individualized drugs a reality
The First Biosimilar Epoetin: But How Similar Is It?
Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
Immunogenicity and aggregation of therapeutic proteins - American ...
Huub Schellekens | European Association of Hospital Pharmacists
Biosimilars bieden oplossing voor stijgende kost onco- en hematologische behandelingen - Actualiteit - Belgian Oncology & Hematology News - Artsenkrant.com
Immunogenicity and glycosylation: The key issues for biosimilars - ppt video online download
Huub Schellekens – Studium Generale Universiteit Utrecht
Zo kan Nederland zich beter wapenen tegen epidemieën
Huub Schellekens - HR Business Partner - Feenstra | LinkedIn
Pharmaceutical Technology Europe - August 2010 - What is Hindering the Uptake of Biosimilars
Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
Heidi Schellekens - massage & bewustwording Utrecht | Utrecht
Peperduur medicijn voor een schijntje nagemaakt | De Volkskrant
PDF) Biosimilar therapeutics—What do we need to consider?
Huub Schellekens, Professor of pharmaceutical biotechnology at Utrecht University: "We need 20 billion doses for the entire world population"
Biosimilars are as safe and efficient for use as cancer medication as the original - News - Utrecht University
Huub Schellekens – Studium Generale Universiteit Utrecht
Impact of Biosimilar Insulins on Clinical Practice
Huub Schellekens, Professor of pharmaceutical biotechnology at Utrecht University: "We need 20 billion doses for the entire world population"
PDF) Immunogenicity of mAbs in non-human primates during nonclinical safety assessment | Beatriz Silva Lima - Academia.edu
PDF) Challenges in standardizing safety assessments of biopharmaceuticals, the case of EPREX Associated Pure Red Cell Aplasia | Toine Pieters - Academia.edu
Huub Schellekens - HR Business Partner - Feenstra | LinkedIn
Huub Schellekens's research works | Utrecht University, Utrecht (UU) and other places
Catalogus Professorum - Prof Detail
PDF) Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates
BIOLOGICALS UIT DE BIO-NESPRESSO?
